Globus Medical, Inc. (GMED)

Globus Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	423.78	102.98	122.87	190.17	149.19	102.29
Depreciation & Amortization	275.71	254.02	144.73	68.25	69.87	62.87
Loss (Gain) From Sale of Assets	11.3	5.55	1.54	0.3	0.46	0.81
Asset Writedown & Restructuring Costs	-	12.61	-	0.15	34.31	24.42
Loss (Gain) From Sale of Investments	-0.99	-0.64	0.79	5.39	2.78	0.59
Stock-Based Compensation	50.27	54.19	52.74	32.81	30.59	27.07
Provision & Write-off of Bad Debts	6.63	16.99	3.66	-0	1.2	2.96
Other Operating Activities	-33.48	172.48	33.76	-13.34	5.13	15.38
Change in Accounts Receivable	34.45	-78.06	-49.91	-50.84	-25.9	10.7
Change in Inventory	-29.31	-29.86	-70.33	-61.75	-11.97	-50.11
Change in Accounts Payable	15.72	17.66	-14.22	14.42	3.68	-6.35
Change in Income Taxes	-66.44	-13.38	-0.41	-2.89	5.21	1.66
Change in Other Net Operating Assets	27.55	6.08	18.28	-4.21	11.72	6.52
Operating Cash Flow	715.2	520.64	243.5	178.47	276.27	198.79
Operating Cash Flow Growth	72.35%	113.81%	36.44%	-35.40%	38.98%	15.59%
Capital Expenditures	-135.59	-115.43	-78.27	-74.05	-56.9	-63.66
Cash Acquisitions	-252.55	-17.64	-296.03	-31.44	-34.49	-33.48
Investment in Securities	50.12	-42.99	677.27	-4.88	-284.55	-20.18
Investing Cash Flow	-347.69	-176.05	302.97	-110.36	-375.94	-117.32
Issuance of Common Stock	96.28	110.44	12.4	41.72	63.5	72.32
Repurchase of Common Stock	-259.08	-92.52	-236.18	-144.49	-	-104.67
Other Financing Activities	-19.86	-45.62	-8.04	-7.19	-9.35	-6.32
Financing Cash Flow	-632.64	-27.7	-231.82	-109.96	54.15	-38.66
Foreign Exchange Rate Adjustments	14.13	0.26	2.18	-0.75	-0.81	0.87
Net Cash Flow	-251	317.15	316.83	-42.6	-46.33	43.67
Free Cash Flow	579.61	405.21	165.23	104.42	219.38	135.14
Free Cash Flow Growth	97.30%	145.25%	58.23%	-52.40%	62.34%	33.50%
Free Cash Flow Margin	20.93%	16.08%	10.53%	10.21%	22.90%	17.13%
Free Cash Flow Per Share	4.21	2.94	1.44	1.02	2.12	1.34
Cash Income Tax Paid	136.13	158.51	100.59	77.82	45.03	25.44
Levered Free Cash Flow	400.2	598.37	-346.92	75.52	160.53	88.28
Unlevered Free Cash Flow	400.2	600.98	-346.92	75.52	160.53	88.28
Change in Working Capital	-18.02	-97.55	-116.6	-105.26	-17.25	-37.59

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q